ArriVent BioPharma, Inc.（AVBP）價格預測AVBPArriVent BioPharma, Inc.

Alphio's AVBP stock price prediction model matches the current ArriVent BioPharma, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $16.87 (+1.24%). The 1-week path is $16.57 (-0.53%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Currently, Arrivent Biopharma Inc (AVBP) is not a good buy. The stock has plummeted 48% following a failed clinical trial, and the current price is $16.66, significantly below recent analyst price targets ranging from $18 to $29. The RSI is at a low 25.154, indicating oversold conditions, but the overall financial outlook remains negative with a forward P/E of 0 and a net income loss of $49.89 million in Q2 2026. The main risk is the ongoing negative sentiment due to the trial failure, which has led to a drastic drop in stock price and market confidence.

ArriVent BioPharma, Inc. (AVBP) last closed at $16.66, losing -0.77%. These facts feed the 1-day and 1-week AVBP price prediction above.